Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00589225 · ClinicalTrials.gov registry record
Primary Hyperoxaluria Mutation Genotyping
A clinical trial of Primary Hyperoxaluria, sponsored by Mayo Clinic.
- Completed
- Registry status
- 902
- Enrollment target
- 1
- Study location
NCT00589225: Completed study of Primary Hyperoxaluria, sponsored by Mayo Clinic.
NCT00589225 is a study of Primary Hyperoxaluria that has completed, run by Mayo Clinic. The registered enrollment target is 902 participants, roughly in line with the 922-participant average among 3 other Primary Hyperoxaluria trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00589225, a study of Primary Hyperoxaluria, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 902 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will help us determine whether certain genetic mutations, more than others, are a cause of more severe disease in Primary Hyperoxaluria.
Conditions Studied
Interventions
- GENETIC Genetic Analysis
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 902 participants |
| Start Date | 2003-12 |
| Est. Completion | 2014-09 |
What the finished NCT00589225 record still lists
NCT00589225 is an observational study that tracks outcomes without assigning an intervention. The registered 902 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 922-participant average among 3 other Primary Hyperoxaluria trials with a reported enrollment target.
The record links to 1 condition, with Primary Hyperoxaluria appearing as the primary indexed condition, and to 1 intervention - of which Genetic Analysis is the first listed.
NCT00589225 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00589225 about?
NCT00589225 is a clinical study titled "Primary Hyperoxaluria Mutation Genotyping". This study will help us determine whether certain genetic mutations, more than others, are a cause of more severe disease in Primary Hyperoxaluria.
What is the current status of trial NCT00589225?
This trial is currently completed. The enrollment target is 902 participants. The study started on 2003-12. Estimated completion is 2014-09.
What conditions does trial NCT00589225 study?
This clinical trial studies the following conditions: Primary Hyperoxaluria.
What interventions are being tested in trial NCT00589225?
The interventions under investigation include: Genetic Analysis (GENETIC).
Who is sponsoring clinical trial NCT00589225?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00589225 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Hyperoxaluria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05769777 · 901 participants · Phase 2
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia